Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2016 |
13,006 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2016 |
13,006 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2016 |
253,236 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2016 |
169,295 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
448,587 |
CARE_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
448,543 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2016 |
190,767 |
PMTCT_ARV |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2016 |
22,504 |
PMTCT_ARV |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2016 |
22,055 |
PMTCT_STAT |
By: Known positives at entry |
2016 |
22,504 |
PMTCT_STAT |
Number of new ANC and L&D clients |
2016 |
71,090 |
PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2016 |
71,090 |
PMTCT_STAT |
Sum of Positives Status disaggregates |
2016 |
22,504 |
TB_SCREEN |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
448,587 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2016 |
158,884 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2016 |
106,871 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2016 |
282,525 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2016 |
265,755 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
265,755 |